inhibitors

BOSTON and LONDON, July 10, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today…

Exton, Pennsylvania, June 28, 2023 (GLOBE NEWSWIRE) -- With the U.S. FDA approval of Apellis’ Syfovre (pegcetacoplan) on February 17th, 2023 for the treatment of geographic atrophy (GA), patients gained access to the first and only…

New York, USA, June 07, 2023 (GLOBE NEWSWIRE) -- AXL Inhibitors Clinical Trial Pipeline Insights Featuring 16+ Companies | DelveInsight The interest of Pharma and the research community in AXL inhibitors as anticancer agents has…

Newark, New Castle, USA, May 31, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global 5-alpha-reductase inhibitors (5-ARIs) market was conducted by Growth Plus Reports in 2022. The market is expected to hit a revenue CAGR of 4.46%…

<!-- Name:DistributionId Value:8845606 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:8777 -->…

<!-- Name:DistributionId Value:8845494 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

<!-- Name:DistributionId Value:8842800 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

<!-- Name:DistributionId Value:8841221 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

<!-- Name:DistributionId Value:8838316 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:2790 -->…

<!-- Name:DistributionId Value:8831878 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value: -->…